KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Accounts Payables (2016 - 2025)

Opko Health (OPK) has disclosed Accounts Payables for 16 consecutive years, with $41.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables fell 12.68% year-over-year to $41.1 million, compared with a TTM value of $41.1 million through Dec 2025, down 12.68%, and an annual FY2025 reading of $41.1 million, down 12.68% over the prior year.
  • Accounts Payables was $41.1 million for Q4 2025 at Opko Health, down from $50.8 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $162.7 million in Q1 2021 and bottomed at $41.1 million in Q4 2025.
  • Average Accounts Payables over 5 years is $73.5 million, with a median of $68.3 million recorded in 2022.
  • The sharpest move saw Accounts Payables skyrocketed 98.14% in 2021, then tumbled 47.3% in 2022.
  • Year by year, Accounts Payables stood at $82.0 million in 2021, then fell by 18.34% to $67.0 million in 2022, then increased by 4.01% to $69.7 million in 2023, then plummeted by 32.44% to $47.1 million in 2024, then decreased by 12.68% to $41.1 million in 2025.
  • Business Quant data shows Accounts Payables for OPK at $41.1 million in Q4 2025, $50.8 million in Q3 2025, and $56.7 million in Q2 2025.